LTFS
TCON

Ladenburg Thalmann Financial Services’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$0 Hold
2
– – ﹤0.01% 5545
2019
Q3 		$0 Hold
2
– – ﹤0.01% 5495
2019
Q2 		$0 Hold
2
– – ﹤0.01% 5451
2019
Q1 		$0 Hold
2
– – ﹤0.01% 5375
2018
Q4 		$0 Hold
2
– – ﹤0.01% 5371
2018
Q3 		$1K Buy
+2
New +$926 ﹤0.01% 5060

Other funds holding TCON

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
PCM
Puissance Capital Management New York $17.3M AUM 149.36% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Ladenburg Thalmann Financial Services's TCON Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its TRACON Pharmaceuticals, Inc. Common Stock (TCON) position steady in Q4 2019 at 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5545.

Ladenburg Thalmann Financial Services first reported a position in TCON in Q3 2018 and has held it in 6 quarters since. The position peaked at $1K in Q3 2018. 15 funds tracked by Wall St. Rank hold TCON as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 2 shares of TRACON Pharmaceuticals, Inc. Common Stock worth $0 as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its TRACON Pharmaceuticals, Inc. Common Stock share count unchanged in Q4 2019.
  • TRACON Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5545 holding.
  • Ladenburg Thalmann Financial Services first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q3 2018 and has held it in 6 quarters since.
  • Ladenburg Thalmann Financial Services's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $1K in Q3 2018.
  • 15 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.